Survey of Payers and Gastroenterologists Finds Excitement Over the Prospect of JAK Inhibitors to Treat Inflammatory Bowel Disease

BURLINGTON Mass. Aug. 8 2017 PRNewswire Decision Resources Group finds that surveyed health insurance medical and pharmacy directors as well as gastroenterologists look favorably on Janus kinase JAK inhibitors for use in Inflammatory Bowel Disease IBD. A...